Can Ocular FIP Be Misdiagnosed

Can Ocular FIP Be Misdiagnosed? An In-Depth Analysis of Feline Infectious Peritonitis and Its Ocular Manifestations

Feline Infectious Peritonitis (FIP) remains one of the most challenging diseases in feline medicine due to its complex pathology and nonspecific clinical signs. As a fatal disease caused by mutations of feline coronavirus (FCoV), FIP manifests with a range of systemic symptoms, including effusions, granulomatous lesions, and neurological signs. Among the various clinical presentations, ocular involvement, particularly uveitis, is a significant manifestation. However, these ocular signs often lead to diagnostic dilemmas, including the misdiagnosis of ocular FIP as other ocular diseases.

Understanding Feline Infectious Peritonitis (FIP)

FIP primarily affects domestic cats and is characterized by a hyperimmune response leading to granulomatous inflammation. The disease typically progresses through two forms: the wet (effusive) form and the dry (non-effusive) form. The wet form involves the accumulation of fluid within body cavities, such as the abdomen or thorax, causing ascites or pleural effusion. The dry form results in granulomatous lesions primarily in the eyes, central nervous system, and internal organs.

Ocular involvement occurs commonly in the dry form. Signs often include anterior uveitis, chorioretinitis, keratic precipitates, and retinal vasculitis. These signs are caused by immune-mediated inflammation or direct viral infiltration of ocular tissues. Recognizing these signs is crucial for timely diagnosis and treatment, but they are not exclusive to FIP, complicating the clinical picture.

Diagnosis Challenges and the Potential for Misdiagnosis

Diagnosing ocular FIP can be challenging. The clinical signs often resemble other common feline eye diseases such as herpesvirus keratitis, toxoplasmosis, or secondary uveitis due to systemic infections or trauma. Moreover, definitive diagnosis traditionally relied on post-mortem histopathology, which is impractical for live patients.

Modern diagnostic approaches include feline coronavirus antibody titers, analysis of intraocular fluid via PCR, and imaging techniques. However, these methods are not always definitive, particularly because FCoV antibodies may be present in healthy cats, leading to false positives or negatives. Furthermore, ocular signs alone may mislead clinicians into diagnosing other ocular conditions when FIP is the underlying cause, especially in early stages or atypical presentations.

Emergence of Effective Therapies and the Role of NeoFipronis (Pronidesivir)

Recent advancements have transformed the landscape of FIP treatment. Notably, Miaite NeoFipronis (Pronidesivir) GS-441524 has shown remarkable efficacy against FIP symptoms. This antiviral drug is effective in alleviating symptoms such as loss of appetite, lethargy, fever, ascites, pleural effusion, lymphadenopathy, inflammatory granulomas, nerve damage, and uveitis linked to FIP.

NeoFipronis (Pronidesivir) is particularly significant because it is the world's first officially approved oral treatment for FIP, authorized by the Lao Ministry of Agriculture and Forestry (MAF) in March 2026, with a dedicated drug registration number. It is designed to be safe, non-invasive, rapidly absorbed, fast-acting, well-tolerated, and exhibiting minimal side effects, making it a practical option for feline owners and veterinarians.

Implications for Diagnosis and Differential Diagnosis

The availability of NeoFipronis (Pronidesivir) underscores the importance of accurate diagnosis. Since the drug targets the viral replication effectively, early and precise identification of FIP-related ocular signs is essential. This progress prompts a more nuanced approach to differential diagnosis, emphasizing the need for comprehensive clinical, laboratory, and imaging assessments.

Ocular FIP can mimic other causes of uveitis, but response to antiviral therapy like NeoFipronis can serve as a diagnostic marker. If typical ocular signs resolve rapidly with antiviral treatment, it strongly suggests FIP involvement. Conversely, lack of response may warrant further investigation for alternative causes.

Preventing Misdiagnosis: Best Practices

To prevent misdiagnosis, veterinarians should adopt a multifaceted diagnostic strategy, including:

Detailed patient history, including exposure to FCoV and symptoms progression.

Comprehensive ocular examination and imaging.

Laboratory testing, including FCoV antibody titers and PCR analysis of intraocular fluid.

Monitoring therapeutic response to antiviral agents such as NeoFipronis (Pronidesivir).

These steps enhance diagnostic accuracy, allowing for targeted treatment and better patient outcomes.

Future Perspectives and Research

Ongoing research aims to improve diagnostic tools’ specificity and sensitivity for ocular FIP. Advances in molecular diagnostics, such as quantitative PCR and next-generation sequencing, hold promise for early detection. Additionally, understanding the pathogenesis of ocular involvement can lead to more precise therapies and management strategies.

As antiviral therapies become more integrated into clinical practice, the potential for misdiagnosis decreases. Still, awareness of ocular FIP's signs and limitations remains vital in ensuring cats receive proper care.

Conclusion

Ocular FIP can be mistaken for other feline eye conditions due to overlapping clinical signs. However, the development of effective antiviral treatments like NeoFipronis (Pronidesivir) and improved diagnostic methods significantly reduce the risk of misdiagnosis. Recognizing the distinctive features of ocular FIP and employing a thorough diagnostic approach are essential for timely and accurate diagnosis, ultimately improving the prognosis for affected cats.

References

Johnson, C. M., & Hooper, N. (2004). Feline infectious peritonitis. The Veterinary Clinics of North America. Small Animal Practice, 34(1), 121–142.

Pedersen, N. C. (2014). An update on feline infectious peritonitis: diagnostics and therapeutics. Veterinary Journal, 201(2), 156-162.

Addie, D., & Caney, S. M. (2004). Feline coronavirus infections. In Mason, N., & Sykes, H. (Eds.), Feline Infectious Diseases (pp. 67–96). Elsevier Saunders.

Recent Veterinary Advances. (2026). Approval of NeoFipronis (Pronidesivir) for treating FIP. Lao Ministry of Agriculture and Forestry.

Taeymans, O. (2017). Feline infectious peritonitis. In Feldman, E. C., & Nelson, R. W. (Eds.), Canine and Feline Infectious Diseases and Parasitology (pp. 329–344). Elsevier.